Preventing type 2 diabetes in communities across the U.S.: The national diabetes prevention program

American Journal of Preventive Medicine

Volumn 44, Issue 4 SUPPL.4, 2013, Pages

  Albright, Ann L ^a   Gregg, Edward W ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNITY; COMMUNITY ASSESSMENT; EPIDEMIC; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; LIFESTYLE MODIFICATION; MARKETING; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION; RECOGNITION; RISK ASSESSMENT; TRAINING; UNITED STATES; WESTERN HEMISPHERE; COST BENEFIT ANALYSIS; ECONOMICS; GLUCOSE TOLERANCE TEST; HEALTH CARE DELIVERY; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH SERVICE; RISK;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HUMANS; LIFE STYLE; PREDIABETIC STATE; RISK; UNITED STATES;

EID: 84880439151     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2012.12.009     Document Type: Article

References (34)

1. CDC. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the U.S., 2011. Atlanta GA: DHHS, 2011
2. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden ofdiabetes in the U.S. adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010; 8: 29-40.
3. Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglyce-mia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007; 78(3): 305-12. (Pubitemid 350030320)
4. CDC. Diabetes public health resource: data and trends. www.cdc.gov/diabetes/surveillance.
5. Li Y, Burrows NR, Gregg EW, Albright A, Geiss LS. Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988-2008. Diabetes Care 2012; 35(2): 273-7.
6. Burrows NR, Li Y, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care 2010; 33: 73-7.
7. Gregg EW, Albright AL. The public health response to diabetes - two steps forward, one step back. JAMA 2009; 301(15): 1596-8.
8. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346(6): 393-403. (Pubitemid 34437694)
9. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344(18): 1343-50. (Pubitemid 32378388)
10. Crandall JP, Knowler WC, Kahn SE, et al. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 2008; 4(7): 382-93. (Pubitemid 351881862)
11. Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006; 368(9548): 1673-9. (Pubitemid 46048554)
12. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008; 371(9626): 1783-9. (Pubitemid 351697954)
13. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374: 1677-86.
14. Gong Q, Gregg EW, Wang J, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 2011; 54(2): 300-7.
15. Herman Wh, Brandle M, Zhang P, et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care 2003; 26(1): 36-47. (Pubitemid 36928992)
16. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008; 31: 596-615.
17. Ali MK, Echouffo-Tcheugui J, Willamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff 2012; 31(1): 67-75.
18. Wing RR, Bahnson JL, Bray GA, et al. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010; 170(17): 1566-75.
19. Rose G, Day S. The population mean predicts the number of deviant individuals. BMJ 1990; 301(6759): 1031-4. (Pubitemid 20381083)
20. Manuel DG, Lim J, Tanuseputro P, et al. Revisiting Rose: strategies for reducing coronary heart disease. BMJ 2006; 332(7542): 659-62. (Pubitemid 44365729)
21. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ 2011; 343: d7163.
22. Zhuo X, Zhang P, Selvin E, et al. Alternative A1c cutoffs to identify high-risk adults for diabetes prevention: a cost-effectiveness perspective. Am J Prev Med 2012; 42(4): 374-81.
23. Gregg EW, Geiss L, Zhang P, Zhuo X, Williamson DF, Albright A. Implications of risk stratification for diabetes prevention: the case of hemoglobin A1c. Am J Prev Med 2013; 44(4S4): S375-S380.
24. Lin JS, O'Connor E, Whitlock EP, Beil TL. Behavioral counseling to promote physical activity and a healthful diet toprevent cardiovascular disease in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2010; 153(11): 736-50.
25. Colagiuri R, Colagiuri S, Yach D, Pramming S. The answer to diabetes prevention: science, surgery, service delivery, or social policy? Am J Public Health 2006; 96(9): 1562-9. (Pubitemid 44300913)
26. Popkin BM, Haines PS, Reidy KC. Food consumption trends of U.S. women: patterns and determinants between 1977 and 1985. Am J Clin Nutr 1989; 49(6): 1307-19. (Pubitemid 19169697)
27. Nielsen SJ, Popkin BM. Patterns and trends in food portion sizes, 1977-1998. JAMA 2003; 289(4): 450-3. (Pubitemid 36119965)
28. Brownell KD, Farley T, Willett WC, et al. The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med 2009; 361(16): 1599-605.
29. Soler RE, Leeks KD, Razi S, et al. A systematic review of selected interventions for worksite health promotion. The assessment of health risks with feedback. Am J Prev Med 2010; 38(2S): S237-S262.
30. Hu FB, Malik VS. Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav 2010; 100(1): 47-54.
31. Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med 2007; 357(4): 370-9. (Pubitemid 47124137)
32. Khan LK, Sobush K, Keener D, et al. Recommended community strategies and measurements to prevent obesity in the U.S. MMWR Re-comm Rep 2009; 58(RR-7): 1-26.
33. Ludwig J, Sanbonmatsu L, Gennetian L, et al. Neighborhoods, obesity, and diabetes - a randomized social experiment. N Engl J Med 2011; 365: 1509-19.
34. Kansagra SM, Farley TA. Public health research: lost in translation or speaking the wrong language. Am J Public Health 2011; 101(12): 2203-6.